Drug Profile
Glycopyrrolate/rivastigmine - Sio Gene Therapies
Alternative Names: RVT-104Latest Information Update: 23 Nov 2020
Price :
$50
*
At a glance
- Originator Axovant Sciences
- Class Antidementias; Phenylcarbamates; Pyrrolidines; Quaternary ammonium compounds; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors; Butyrylcholinesterase inhibitors; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alzheimer's disease; Lewy body disease